Product Information
BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.6695 per EA under NDC 00054018913. Its NADAC has been published 620 times since Aug 13, 2014.
BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET
buprenorphine hydrochloride and naloxone hydrochloride dihydrateStrength
8; 2 mg/1; mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054018913
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Last Updated
6/17/2026
Active Ingredients
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA203326On Market Since
6/27/2014
Pharmacological Classes
Price Statistics
The NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has been published 620 times since Aug 13, 2014, and over the history we have for it it has declined 89.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6695 per EA |
|---|---|
| All-time high | $6.1950 (Aug 13, 2014) |
| All-time low | $0.6450 (Nov 20, 2024) |
| 52-week high | $0.7397 |
| 52-week low | $0.6616 |
| Median price | $1.3372 |
| Average price | $2.2823 |
| Largest weekly change | +29.6% (Aug 21, 2024) |
| Weeks tracked | 620 |
| Tracking since | Aug 13, 2014 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.6695 per EA (NDC 00054018913), effective Jun 24, 2026.
How has the price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET changed over time?
Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has declined 89.2%. It has been tracked across 620 weekly CMS publications since Aug 13, 2014.
What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
Since Aug 13, 2014, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has ranged from a low of $0.6450 (Nov 20, 2024) to a high of $6.1950 (Aug 13, 2014), with a median of $1.3372 per EA.
Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET, but none are currently priced below it.
Who manufactures BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?
BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET (NDC 00054018913) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification